EDITORIAL
Published on 23 Nov 2021
Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors
doi 10.3389/fimmu.2021.804735
- 1,313 views
- 1 citation
- Frontiers in Immunology
- B Cell Biology
- Research Topics
- New Insights on Bruton’s Tyrosine Kinase Inhibitors
New Insights on Bruton’s Tyrosine Kinase Inhibitors
26k
Total Downloads
79k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 03 Nov 2021
Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures
doi 10.3389/fimmu.2021.662223
- 22,136 views
- 81 citations
REVIEW
Published on 19 Jul 2021
Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors
doi 10.3389/fimmu.2021.694853
- 11,680 views
- 39 citations
MINI REVIEW
Published on 01 Jul 2021
BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects
doi 10.3389/fimmu.2021.686768
- 14,113 views
- 45 citations
REVIEW
Published on 23 Jun 2021
Targeting Bruton’s Tyrosine Kinase in CLL
doi 10.3389/fimmu.2021.687458
- 13,260 views
- 53 citations
REVIEW
Published on 10 Jun 2021
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway
doi 10.3389/fimmu.2021.689472
- 11,477 views
- 41 citations
Published in
Frontiers in Immunology
- B Cell Biology
Impact
- 79kTopic views
- 51kArticle views
- 26kArticle downloads